L-citrulline: the evidence, the dose, and the citrulline malate problem

L-citrulline exists as a supplement because of one genuinely surprising fact: if you want more arginine in your blood, arginine is not the best thing to swallow. Oral arginine is largely dismantled before it ever reaches the systemic circulation; citrulline slips past that checkpoint and is converted into arginine downstream. That is a real, replicated pharmacological result, and it is the entire reason the product category exists. What gets built on top of it — bigger pumps, more reps, lower blood pressure, better erections — is a much shakier structure, and it is made shakier still by a labelling quirk that means two tubs both marked “8 g” can contain very different amounts of the active compound.

The counterintuitive part: why citrulline beats arginine at being arginine

Nitric oxide (NO) relaxes blood vessels and increases blood flow, and the enzymes that make it — nitric oxide synthases — run on the amino acid L-arginine. The obvious move is therefore to swallow L-arginine. It works far less well than it should, for two reasons.

The first is arginase. Arginine sits at the junction of the urea cycle and NO synthesis, and arginase — abundant in the intestinal wall and the liver — competes directly with NO synthase for it, hydrolysing arginine to ornithine and urea.^[3] An oral arginine dose meets a wall of that enzyme in the enterocytes before it goes anywhere else. The second is the sheer scale of splanchnic first-pass handling. Stable-isotope work in healthy men found that 16 ± 2% of the body’s entire daily nitrate production — nitrate being the stable end-product of NO — came from dietary arginine metabolised during its first pass through the splanchnic region.^[2] A large share of what you swallow is dealt with locally, in the gut, before the rest of you sees it.

Worth being precise about one detail, because supplement copy usually gets it wrong: this is mostly an intestinal problem, not a hepatic one. In the only human study to sample the portal vein directly — twenty patients undergoing liver surgery, with blood drawn from artery, portal vein, hepatic vein and renal vein — the liver extracted just 11.5% of the arginine reaching it, meaning 88% passed through unchanged.^[4] The gut wall, not the liver, is where an oral arginine dose mostly goes to die.

Citrulline is not a substrate for arginase and is not taken up by the same route. The same portal-vein study mapped where it does go: the intestine releases citrulline, the kidney takes it up and releases arginine in exchange — the intestinal–renal axis for arginine synthesis — with the liver extracting only about 8.4% of the citrulline passing through.^[4] So a citrulline capsule enters the bloodstream largely intact and is converted into arginine at a site downstream of everything that destroys oral arginine.

The prediction that follows is testable, and it has been tested. In a double-blind, randomized, placebo-controlled crossover study, 20 healthy volunteers took six different dosing regimens of placebo, citrulline and arginine for a week each. L-citrulline dose-dependently increased both the AUC and the peak concentration of plasma L-arginine more effectively than L-arginine itself did (P < 0.01). At the highest dose — 3 g twice daily — the arginine/ADMA ratio rose from 186 ± 8 to 278 ± 14, urinary nitrate from 92 ± 10 to 125 ± 15 µmol/mmol creatinine, and urinary cGMP from 38 ± 3.3 to 50 ± 6.7 nmol/mmol creatinine.^[1] Every one of those is a marker of increased NO signalling.

Two honest qualifiers belong immediately next to that result. First, in the same study no treatment improved flow-mediated dilation over baseline — the biomarkers moved, the measured vascular function did not.^[1] Second, the arginine advantage is dose-dependent rather than absolute: in a separate crossover comparing 6 g/day of each for a week in ten men, plasma arginine rose by a similar magnitude on citrulline and on arginine — yet only citrulline lowered mean arterial pressure and improved exercise measures.^[7] The pharmacokinetic story is solid; the leap from “more arginine in plasma” to “more NO where you want it” is where the certainty starts leaking out.

There is also a plain practical advantage. Arginine is a gut irritant at the doses people take: across the clinical literature, single doses above about 9 g provoke nausea, cramping and diarrhoea in a meaningful fraction of healthy people, an effect that is itself NO-mediated in the small intestine.^[6] Citrulline is conspicuously better behaved — in a formal dose-ranging study, eight fasting men took single oral loads of 2, 5, 10 and 15 g and none of them experienced side effects at any dose.^[5] For anyone who tried an arginine pre-workout and spent the session in the bathroom, that difference is not a rounding error.

Citrulline malate, and the ratio nobody prints

Here is the single most useful thing to know before buying anything in this category. Most of the performance research was not done on L-citrulline. It was done on citrulline malate — citrulline paired with malic acid, conventionally in a 2:1 ratio by weight. The standard research dose is 8 g of citrulline malate, and at 2:1 that is roughly 5.3 g of citrulline plus 2.7 g of malate. It is not 8 g of citrulline.

That matters commercially because the ratio is frequently absent from the label. A product listing “8,000 mg citrulline malate” might be 2:1, might be 1:1 (which would be 4 g of citrulline), and occasionally the ingredient panel simply says “citrulline malate” inside a proprietary blend with no gram figure at all. Two tubs with the same headline number can differ by a third or more in the compound the research was actually about. The most recent meta-analysis on citrulline malate makes the point from the research side, closing with a call for “larger trials with verified supplement composition” — the composition of what participants swallowed is not always known even in the studies.^[11]

The malate half is not inert filler, and this is where the literature gets genuinely interesting rather than merely annoying. Malate is a tricarboxylic-acid-cycle intermediate, so it can in principle feed oxidative energy production through anaplerosis. The one study that looked directly at muscle energetics used ³¹P magnetic resonance spectroscopy in 18 men taking 6 g/day of citrulline malate for 15 days and found a 34% increase in the rate of oxidative ATP production during exercise and a 20% increase in the rate of phosphocreatine recovery afterwards — effects the authors attributed specifically to enhanced malate supply driving the TCA cycle, not to nitric oxide.^[14] If that reading is right, citrulline malate and citrulline are not the same supplement at all.

Which brings us to a gap that is easy to state and has simply never been filled: no trial has compared citrulline malate against a dose-matched amount of pure L-citrulline. We looked for this from the other direction too — searching for studies of citrulline malate versus citrulline alone rather than only for citrulline-versus-placebo work — and the nearest thing that exists compares citrulline malate against beetroot juice, or against L-arginine, which answers a different question. The 2019 meta-analysis flags “the form of citrulline supplement” explicitly as a moderator that has not been elucidated.^[9] So the malate contribution is plausible, mechanistically coherent, and formally unknown.

Performance: the famous trial, and what the meta-analyses did to it

Nearly every claim you have read about citrulline and training traces back to one 2010 study. Forty-one men completed two bench-press sessions in a randomized, double-blind, two-period crossover, taking 8 g of citrulline malate before one of them. Repetitions to fatigue at 80% of one-rep max increased from the third set onward, reaching 52.9% more repetitions in the final set, with muscle soreness roughly 40% lower at 24 and 48 hours. Stomach discomfort was reported by 14.6% of subjects.^[8]

A 53% increase in the last set is an enormous effect for a supplement, and it should be read as what it is: a single set, in a small crossover, on the outcome most sensitive to expectancy and set order. It has not been reproduced at anything like that magnitude. Here is what happened when the field was pooled:

• Strength and power, 2019. Twelve studies, 13 independent samples, 198 participants. Citrulline beat placebo (P = 0.036) with a small pooled standardized mean difference of 0.20 (95% CI 0.01–0.39) — and the authors note that the confidence interval of every individual study crossed the line of null effect.^[9]
• Repetitions to failure, 2021. Eight studies, 137 participants. 6–8 g of citrulline malate 40–60 minutes before training increased repetitions by 3 ± 5 reps (6.4 ± 7.9%), P = 0.022, SMD 0.196. Split by region, neither subgroup reached significance on its own: lower body 8.1% (P = 0.051), upper body 5.7% (P = 0.131).^[10]
• Everything, 2026. A three-level meta-analysis of 30 randomized trials contributing 138 effect sizes from 644 participants found g = 0.16 (P = 0.01) with wide prediction intervals and limited statistical power; perceived exertion was not significantly affected; subgroup differences by sex, training status, dose and timing were all non-significant; and GRADE certainty ranged from low to very low.^[11]

Three independent teams, three effect sizes between 0.16 and 0.20. That is a consistent answer, and the answer is small. Roughly three extra repetitions across a session is real if you are counting, and invisible if you are not. For comparison, this is a fraction of the effect creatine produces on the same sort of outcome, at a similar price.

Aerobic performance is weaker still. A 2022 meta-analysis of 10 studies found no significant effect on aerobic performance (SMD 0.15, 95% CI −0.02 to 0.32, P = 0.08), and null results for rate of perceived exertion, V̇O₂ kinetics and lactate.^[12] Individual trials do sit on the positive side of that null: 6 g/day for a week improved tolerance to severe-intensity cycling from 589 ± 101 to 661 ± 107 seconds and increased total work done,^[7] and 2.4 g/day for a week cut 4-km time-trial time by 1.5% in 22 trained men — a study run by the healthcare-products division of a company that manufactures citrulline, which is disclosed in the paper and worth knowing.^[13]

Blood pressure and vascular function

This is the endpoint where the mechanism should pay off most directly, and the data are moderate rather than convincing. A systematic review and meta-analysis pooled 8 trials (10 datasets) of oral L-citrulline at 3–9 g/day for 1 to 17 weeks, with individual sample sizes of 12 to 34 participants. Systolic blood pressure fell by 4.10 mmHg (95% CI −7.94 to −0.26; P = 0.037). Diastolic pressure fell by 2.08 mmHg but did not reach significance overall (95% CI −4.32 to 0.16; P = 0.069) — it became significant only in the subgroup using ≥6 g/day (−2.75 mmHg; 95% CI −5.37 to −0.12).^[15]

Read that confidence interval carefully. The upper bound is −0.26 mmHg — the pooled result is significant by a hair, from a base of eight small studies. And there is a second reason for caution that rarely gets mentioned: a separate meta-analysis of citrulline and blood pressure, published in the Journal of Human Hypertension in 2019, was retracted in 2021.^[16] We have deliberately not cited its numbers. When a two-paper literature loses one paper to retraction, the surviving estimate deserves to be held loosely rather than quoted as a fact.

On vascular function as opposed to pressure, the honest position is that the biomarkers move further than the physiology. The pharmacokinetic study that established citrulline’s advantage found no improvement in flow-mediated dilation from any treatment, although pooled analysis showed a correlation between the rise in the arginine/ADMA ratio and improvement in FMD.^[1] A comprehensive review of citrulline and cardiometabolic health reaches a consistent verdict: promise as a blood-pressure intervention in adults with pre-hypertension or hypertension, preclinical (animal) evidence for endothelial protection, and preliminary evidence for muscle and metabolic benefit in older populations — all of which is a fair description of a field that has not yet produced a hard outcome.^[19] Nobody has shown citrulline prevents a stroke or a heart attack, and no trial has been designed to.

Erectile dysfunction: a pilot, and only a pilot

The rationale is sound — penile erection is an NO-dependent event, and it is exactly the arginase problem that made oral arginine a disappointing ED treatment. The evidence, however, is one small study, and it deserves to be described accurately rather than cited as “clinically proven”.

In a single-blind study, 24 men with mild ED (erection hardness score of 3, mean age 56.5 ± 9.8) took placebo for one month and then L-citrulline 1.5 g/day for a second month. Erection hardness improved from 3 to 4 — mild ED to normal function — in 12 of 24 men (50%) on citrulline versus 2 of 24 (8.3%) on placebo (P < .01), and monthly intercourse rose from 1.37 ± 0.93 at baseline to 2.3 ± 1.37 on treatment. There were no adverse events. The authors’ own conclusion is the one usually left out of the marketing: citrulline is “less effective than phosphodiesterase type-5 enzyme inhibitors” and its role “deserves further research.”^[17]

Fifteen years later, that further research has not arrived in the form you would want. We searched for it specifically — not just for “citrulline improves erections” but for any subsequent randomized trial of citrulline on its own for ED. What exists instead are combination products. The closest near-miss is a randomized, double-blind, placebo-controlled crossover pilot in which men with ED despite on-demand PDE5-inhibitor use added L-citrulline 800 mg/day plus trans-resveratrol 300 mg/day: mean SHIM score rose from 8.32 ± 1.21 to 10.96 ± 1.21 versus 8.31 on placebo (P < .05), but erection hardness score did not change significantly, only 13 of 20 enrolled men completed, and the design cannot separate the citrulline from the resveratrol or from the PDE5 inhibitor everyone was still taking.^[18]

The other route to nitric oxide — and why it matters here

Citrulline is not the only way to raise NO, and the alternative is not a competitor so much as a different piece of machinery. There are two physiological routes: the NOS-dependent pathway, in which the NO synthase enzymes oxidise L-arginine (this is where citrulline acts, as a secondary donor by way of arginine), and the NOS-independent pathway, in which dietary nitrate and nitrite are reduced to NO.^[20] They run in opposite chemical directions and they are limited by different things.

The practical consequence is that the NOS-dependent route needs oxygen and functioning enzymes, while the nitrate route works best precisely where oxygen is scarce — hard-working muscle, ischaemic tissue. If your goal is blood pressure, the nitrate literature is deeper: it has a dose-response relationship, a measured pharmacokinetic curve, and a four-week randomized trial in hypertensive patients, and we cover its real size and its limits in beetroot and dietary nitrate. If your goal is resistance training, the citrulline malate literature is the one with repetitions-to-failure outcomes. Stacking both is common in pre-workouts and is untested as a combination for additive benefit — the one trial pairing them was designed to compare them, not to add them.

The other shared limitation is worth stating plainly: the same review that separates the two pathways also found that training status governs whether either helps. Untrained and moderately trained people show improved exercise tolerance with NO donors; highly trained subjects show no benefit.^[20] That pattern holds across this whole category and is a better predictor of whether a supplement will do anything for you than the mechanism is.

Dose, timing, tolerability, cost

Pure L-citrulline, taken daily. The blood-pressure trials used 3–9 g/day, with the diastolic effect appearing only at ≥6 g/day.^[15] Exercise studies have used 6 g/day for a week^[7] and 2.4 g/day for a week.^[13] A reasonable daily range is 3–6 g, split or single, taken consistently rather than occasionally — most of the positive signals came after several days of loading, not from a first dose.

Citrulline malate, taken before training. The meta-analytic sweet spot is 6–8 g of citrulline malate 40 to 60 minutes before the session — about 4–5.3 g of actual citrulline at a 2:1 ratio.^[10] Timing matters mechanistically: plasma arginine peaks roughly 1.2 to 2.3 hours after an oral citrulline load depending on dose.^[5]

There is a ceiling, and it is renal. The dose-ranging study is unusually informative here. Across single loads of 2, 5, 10 and 15 g, plasma arginine rose — but at the highest doses citrulline accumulated in plasma while arginine rose less than expected, which the authors attribute to saturation of the renal conversion of citrulline into arginine. Urinary excretion of citrulline stayed below 5% even at 15 g, and insulin and growth hormone were unaffected.^[5] Two things follow. Mega-dosing does not buy proportionally more arginine, so there is no reason to go past the studied range. And because the conversion step is the kidney’s job, impaired renal function is a genuine reason to ask a clinician first rather than a boilerplate one.

Tolerability is citrulline’s quiet advantage. No side effects were reported at single doses up to 15 g in the dose-ranging study,^[5] against arginine’s well-documented GI toxicity above roughly 9 g in a single dose.^[6] The one caveat comes from the citrulline malate side: 14.6% of subjects in the bench-press trial reported stomach discomfort at 8 g, so the malate load, the empty stomach, or both are worth accounting for if you take it pre-workout.^[8]

Cost is the least of the problems. Bulk L-citrulline and citrulline malate are commodity ingredients produced by fermentation and sold by many suppliers; at 6 g/day, a month costs the price of a coffee or two, which is a materially different value proposition than a branded longevity ingredient. That cheapness is also why it appears in almost every pre-workout blend: it is a credible-sounding label ingredient that costs the formulator very little — which is exactly why it so often appears at a fraction of the studied dose, or inside a proprietary blend where the dose is unknowable.

The honest bottom line

Citrulline is one of the few supplements whose central claim survives scrutiny intact. Well supported: oral L-citrulline raises plasma L-arginine more efficiently than oral L-arginine does, because it bypasses the intestinal arginase and splanchnic first-pass metabolism that consume an arginine dose, and is converted to arginine in the kidney instead.^[1][4] It is also markedly easier on the gut than arginine.^[5][6] Supported, but small: a pooled ergogenic effect of about 0.16–0.20 standardized mean difference — roughly three extra repetitions — at low to very low GRADE certainty,^[9][10][11] and a systolic blood-pressure reduction of about 4 mmHg from eight small trials whose confidence interval barely clears zero.^[15] Not supported: aerobic performance,^[12] any hard cardiovascular outcome, and any ED claim stronger than “one single-blind pilot in mild cases.”^[17] Unknown: whether the malate in citrulline malate does anything on its own.

The way to use that: buy it as a cheap, well-tolerated, small-effect training aid or a modest blood-pressure adjunct, at a dose you can actually count from the label — and not as a nitric oxide breakthrough. The mechanism is better than the outcomes, and the gap between the two is where this entire category makes its money.

This article is research information, not medical advice. L-citrulline and citrulline malate are dietary supplements with no FDA approval for any indication, and are not approved to treat erectile dysfunction, high blood pressure or any other condition. Because citrulline works by increasing nitric oxide signalling, its blood-pressure effect is additive with antihypertensive drugs and it should be discussed with a prescriber before use alongside nitrates or PDE5 inhibitors such as sildenafil or tadalafil. Conversion of citrulline to arginine happens in the kidney, so anyone with impaired renal function should ask a clinician before supplementing. Erectile dysfunction can be an early sign of cardiovascular or metabolic disease and warrants a medical evaluation rather than a self-directed supplement trial.